Cardiff Oncology, Inc. (CRDF) NASDAQ
1.50
+0.015(+1.01%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.50
+0.015(+1.01%)
Currency In USD
| Market Cap | 187.82M |
| Enterprise Value | 171.19M |
| P/E Ratio | -2.28 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 194.69 |
| Price/Book Ratio | 2.94 |
| Enterprise/Revenue | 179.65 |
| Enterprise/EBITDA | -2.06 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -85.26 |
| Operating Margin | -90.34 |
| Return On Assets | -0.91 |
| Return On Equity | -0.95 |
| Revenue | 593,000 |
| Revenue/Share | 0.01 |
| Gross Profit | 593,000 |
| EBITDA | -48.06M |
| Net Income | -45.85M |
| Diluted EPS | -0.69 |
| Total Cash | 46.06M |
| Total Cash/Share | 0.67 |
| Total Debt | 646,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 3.27 |
| Book Value Per Share | 0.51 |
| 52-Week Change | -55.37 |
| 52-Week High | 4.56 |
| 52-Week Low | 1.4 |
| Moving Average 50 Days | 1.69 |
| Moving Average 200 Days | 2.08 |
| Average Volume | 862,688 |
| Shares Outstanding | 68.37M |
| % Held by Institutions | 36.78 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
| Last Split Date | February 20, 2019 |